BRAF and Ehlers-Danlos syndrome, musculocontractural type: EIF1AX mutations were detected in 1–2% of PTCs, largely occurring in a mutually exclusive manner with BRAF and RAS mutations [30], and more frequently in PDTCs (11%) and ATCs (9%) in which, on the contrary, they are strongly associated with RAS mutations [39].